HHS Seeks Info as It Weighs Second Attempt at Drug Rebates (1)

Feb. 13, 2026, 3:15 PM UTCUpdated: Feb. 13, 2026, 5:32 PM UTC

The US Department of Health and Human Services for the second time is seeking information on how it should implement the potential use of rebates in a drug discount program after its first proposal was shot down in federal court.

The request for information issued Friday weighs whether the US government should implement a rebate system under the 340B Drug Pricing Program—a federal plan that historically has required drugmakers to offer up-front discounts to health providers that treat low-income and uninsured patients.

The HHS seeks to understand the administrative, operational, financial, and drug access concerns with rebates, according to the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.